The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...

The carrots, which were sold at supermarket chains nationwide, "should no longer be in grocery stores but may be in consumers' refrigerators or freezers." ...

IQVIA reported annual sales for the twelve months ending September 2024 of $4.3 billion for the brand and generic market for this product.

Grimmway Farms recalled organic carrots after the product was linked to a multi-state E. coli outbreak that has infected 39 ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer and full approval earlier this year, was the key asset in AbbVie's $10.1 billion ...

An outbreak of E. coli has infected dozens of people who ate bagged organic carrots. One person died from the infection. The CDC says 39 people were infected, and 15 ...

CABA-201 safety profile suggests favorable risk-benefit with no CRS or ICANS in the majority of patients; low-grade CRS in three of eight patients and one previously reported ICANS event – – ...

Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8. IM8 launch marks a bold entry into the $187 ...

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically ...